Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: A more precise definition of "isolated" and its possible clinical implications, a collaborative study of the Resistant Disease Committee of the International BFM study group

Blood

Volumn 110, Issue 12, 2007, Pages 4022-4029

  Hagedorn, Nikola ^a   Acquaviva, Cécile ^b   Fronkova, Eva ^c   Von Stackelberg, Arend ^a   Barth, Andrea ^a   Zur Stadt, Udo ^d   Schrauder, André ^e   Trka, Jan ^c   Gaspar, Nathalie ^b   Seeger, Karl ^a   Henze, Günter ^a   Cavé, Hélène ^b   Eckert, Cornelia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c CHARLES UNIVERSITY   (Czech Republic)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE RESISTANCE; FEMALE; GENE REARRANGEMENT; GENETIC HETEROGENEITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLA OBLONGATA; MICROSCOPY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE;

EID: 37049015168     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-04-082040     Document Type: Article

References (40)

1. Gaynon PS, Qu RP, Chappell RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse-the Children's Cancer Group Experience. Cancer. 1998;82:1387-1395.
2. Wheeler K, Richards S, Bailey C, Chessells J. Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience: Medical Research Council Working Party on Childhood Leukaemia. Br J Haematol. 1998;101:94-103.
3. Schroeder H, Garwicz S, Kristinsson J, Siimes MA, Wesenberg F, Gustafsson G. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Med Pediatr Oncol. 1995;25:372-378.
4. Henze G, von Stackelberg A. Treatment of relapsed acute lymphoblastic leukemia. In: Pui CH, ed. Treatment of Acute Leukemias New Directions for Clinical Research. Memphis, TN: Humana Press; 2002.
5. Henze G. Chemotherapy for relapsed childhood acute lymphoblastic leukemia. Intl J Pediatr Hematol/ Oncol. 1998;5:199-213.
6. van der Velden VH, Cazzaniga G, Schrauder A, et al. Analysis of minimal residual disease by Ig/ TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia. 2007;21:604-611.
7. Lal A, Kwan E, al-Mahr M, et al. Molecular detection of acute lymphoblastic leukaemia in boys with testicular relapse. Mol Pathol. 1998;51:277-281.
8. Chessells JM. Relapsed lymphoblastic leukaemia in children: a continuing challenge. Br J Haematol. 1998;102:423-438.
9. Henze G, Fengler R, Hartmann R, et al. Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85): a relapse study of the BFM Group. Blood. 1991;78:1166-1172.
10. Henze G, Fengler R, Hartmann R. Chemotherapy for relapsed childhood acute lymphoblastic leukemia: results of the BFM Study Group. Haematol Blood Transfus. 1994;36:374-379.
11. Goulden N, Langlands K, Steward C, et al. PCR assessment of bone marrow status in 'isolated' extramedullary relapse of childhood B-precursor acute lymphoblastic leukaemia. Br J Haematol. 1994;87:282-285.
12. Neale GA, Pui CH, Mahmoud HH, et al. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia. Leukemia. 1994;8:768-775.
13. O'Reilly J, Meyer B, Baker D, Herrmann R, Cannell P, Davies J. Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukaemia. Leukemia. 1995;9:624-627.
14. Einsiedel HG, von Stackelberg A, Hartmann R, et al. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. J Clin Oncol. 2005;23:7942-7950.
15. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias: European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783-1786.
16. Messina C, Valsecchi MG, Arico M, et al. Autologous bone marrow transplantation for treatment of isolated central nervous system relapse of childhood acute lymphoblastic leukemia: AIEOP/ FONOP-TMO group: Associzione Italiana Emato-Oncologia Pediatrica. Bone Marrow Transplant. 1998;21:9-14.
17. Vilmer E, Suciu S, Ferster A, et al. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report: Children Leukemia Cooperative Group. Leukemia. 2000;14:2257-2266.
18. van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease: Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:1901-1928.
19. Gabert J, Beillard E, van der Velden VH, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program. Leukemia. 2003;17:2318-2357.
20. Taube T, Seeger K, Beyermann B, et al. Multiplex PCR for simultaneous detection of the most frequent T cell receptor-delta gene rearrangements in childhood ALL. Leukemia. 1997;11:1978-1982.
21. Pongers Willemse MJ, Seriu T, et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13:110-118.
22. Szczepanski T, van der Velden VH, Hoogeveen PG, et al. Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells. Blood. 2004;103:3798-3804.
23. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
24. Bottaro M, Berti E, Biondi A, Migone N, Crosti L. Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood. 1994;83:3271-3278.
25. Guidal C, Vilmer E, Grandchamp B, Cave H. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia. Leukemia. 2002;16:762-764.
26. Verhagen OJ, Willemse MJ, Breunis WB, et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia. 2000;14:1426-1435.
27. van der Velden VH, Wijkhuijs JM, Jacobs DC, van-Wering ER, van-Dongen JJ. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia. 2002;16:1372-1380.
28. Eckert C, Landt O. Real-time PCR to detect minimal residual disease in childhood ALL. Methods Mol Med. 2004;91:175-182.
29. van der Velden VHJ, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJM. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia. 2002;16:928-936.
30. Laurendeau I, Bahuau M, Vodovar N, et al. Taq-Man PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem. 1999;45:982-986.
31. Kalbfleisch JD, Prentice. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980.
32. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
33. Bleyer WA. Biology and pathogenesis of CNS leukemia. Am J Pediatr Hematol Oncol. 1989;11:57-63.
34. Haworth C, Heppleston AD, Morris Jones PH, Campbell RH, Evans DI, Palmer MK. Routine bone marrow examination in the management of acute lymphoblastic leukaemia of childhood. J Clin Pathol. 1981;34:483-485.
35. Rogers PC, Bleyer WA, Coccia P, et al. Yield of unpredicted bone-marrow relapse diagnosed by routine marrow aspiration in children with acute lymphoblastic leukaemia: a report from the Children's Cancer Study Group. Lancet. 1984;1:1320-1322.
36. Szczepanski T, Flohr T, van der Velden VH, Bartram CR, van Dongen JJ. Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia. Best Pract Res Clin Haematol. 2002;15:37-57.
37. Yoshihara T, Morimoto A, Kuroda H, et al. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature. Bone Marrow Transplant. 2006;37:25-31.
38. Eckert C, Einsiedel HG, Hartmann R, et al. Clonal stability of initial leukemia in a child with central nervous system relapse 7.4 years after bone marrow relapse of common acute lymphoblastic leukemic. Haematologica. 2004;89:(6)e77-e79.
39. Buhrer C, Hartmann R, Fengler R, et al. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1993;21:470-476.
40. Felix CA, Lange BJ, Chessells JM. Pediatric acute lymphoblastic leukemia: challenges and controversies in 2000. Hematology (Am Soc Hematol Educ Program). 2000;285-302.